Oridonin-induced apoptosis in leukemia K562 cells and its mechanism

被引:1
|
作者
Liu, JJ [1 ]
Huang, RW
Lin, DJ
Wu, XY
Peng, J
Pan, XL
Song, YQ
Lin, Q
Hou, M
Wang, DN
Chen, F
Zhang, MH
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hematol & Oncol, Guangzhou 510630, Guangdong, Peoples R China
[2] Shandong Univ, QiLU Hosp, Dept Hematol & Oncol, Jinan 250012, Shandong, Peoples R China
[3] Peking Univ, Hlth Sci Ctr, Dept Oncol, Beijing 100083, Peoples R China
关键词
oridonin; apoptosis; Bcl-2; Bax; telomerase;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oridonin, an extract from the Chinese herb Rabdosia rubescens, is currently one of the most important traditional Chinese herbal medicines. Recently oridonin has been reported to have anti-tumor effects in a large variety of malignant diseases. In this study, we investigated the apoptotic inducing effect of oridonin in leukemia K562 cells and its mechanism. Cell growth inhibition was measured using a microculture tetrazolium assay, apoptosis was measured by flow cytometry and electron microscopy as well as by DNA fragmentation analysis. Telomerase activity was measured by TRAP-enzyme-linked immunosorbent assay, and the expression of Bcl-2 and Bax proteins was detected by western blot analysis. The results showed that oridonin could inhibit the proliferation and induce apoptosis on leukemia K562 cells remarkably. Telomerase activity as well as Bcl-2 expression was down-regulated, while Bax expression was up-regulated concurrently, when apoptosis ocurred. We therefore conclude that oridonin demonstrated anti-proliferative and apoptosis-inducing effects on K562 cells in vitro, and that changes in bcl-2 and bax protein levels as well as telomerase activity may play an important role in its mechanism of action.
引用
收藏
页码:225 / 230
页数:6
相关论文
共 50 条
  • [21] Apoptosis of K562 leukemia cells by Abnobaviscum F®, a European mistletoe extract
    Park, Yu-Kyoung
    Do, Young Rok
    Jang, Byeong-Churl
    ONCOLOGY REPORTS, 2012, 28 (06) : 2227 - 2232
  • [22] Polyphyllin D induces apoptosis and differentiation in K562 human leukemia cells
    Yang, Chunhui
    Cai, Hong
    Meng, Xiuxiang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 36 : 17 - 22
  • [23] Augmentation of oridonin-induced apoptosis observed with reduced autophagy
    Cui, Qiao
    Tashiro, Shin-ichi
    Onodera, Satoshi
    Ikejima, Takashi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 101 (03) : 230 - 239
  • [24] Involvement of PKC signal pathways in oridonin-induced autophagy in HeLa cells: A protective mechanism against apoptosis
    Zhan, Yahong
    Wu, Yingliang
    Tashiro, Shin-ichi
    Onodera, Satoshi
    Ikejima, Takashi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 378 (02) : 273 - 278
  • [25] Effect of matrine on autophagy and apoptosis of human leukemia K562/IM cells
    胡美薇
    China Medical Abstracts(Internal Medicine), 2018, 35 (02) : 74 - 75
  • [26] Involvement of oxidative stress in taxol-induced apoptosis in chronic myelogenous leukemia K562 cells
    Meshkini, Azadeh
    Yazdanparast, Razieh
    EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 2012, 64 (04) : 357 - 365
  • [27] Effect of cortisol on K562 leukemia cells
    Fonseca, Marcelo de Oliveira
    da Silva, Newton Soares
    Soares, Cristina Pacheco
    MUNDO DA SAUDE, 2019, 43 (04): : 854 - 861
  • [28] Prevention of homoharringtonine induced apoptosis by antioxidanis in K562 cells.
    Mai, Wenyuan
    Lin, Maofang
    Jin, Jie
    BLOOD, 2006, 108 (11) : 172B - 172B
  • [29] Effects of antioxidants on apoptosis induced by dasatinib and nilotinib in K562 cells
    Damiano, Sara
    Montagnaro, Serena
    Puzio, Maria V.
    Severino, Lorella
    Pagnini, Ugo
    Barbarino, Marcella
    Cesari, Daniele
    Giordano, Antonio
    Florio, Salvatore
    Ciarcia, Roberto
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (06) : 4845 - 4854
  • [30] Oridonin-induced ferroptosis and apoptosis: a dual approach to suppress the growth of osteosarcoma cells
    Zhang, Feifan
    Hao, Yang
    Yang, Ning
    Liu, Man
    Luo, Yage
    Zhang, Ying
    Zhou, Jian
    Liu, Hongjian
    Li, Jitian
    BMC CANCER, 2024, 24 (01)